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ABSTRACT
Endonuclease (Endo) IV encoded by denB of
bacteriophage T4 is an enzyme that cleaves
single-stranded (ss) DNA in a dC-specific manner.
Also the growth of dC-substituted T4 phage and
host Escherichia coli cells is inhibited by denB
expression presumably because of the inhibitory
effect on replication of dC-containing DNA.
Recently, we have demonstrated that an efficient
cleavage by Endo IV occurs exclusively at the
5’-proximal dC (dC1) within a hexameric or an
extended sequence consisting of dC residues at
the 5’-proximal and the 3’-proximal positions (dCs
tract), in which a third dC residue within the tract
affects the polarized cleavage and cleavage rate.
Here we isolate and characterize two denB mutants,
denB(W88R) and denB(S176N). Both mutant alleles
have lost the detrimental effect on the host cell.
Endo IV(W88R) shows no enzymatic activity (_0.4%
of that of wild-type Endo IV). On the other hand,
Endo IV(S176N) retains cleavage activity (17.5% of
that of wild-type Endo IV), but has lost the polarized
and restricted cleavage of a dCs tract, indicating
that the Ser
176 residue of Endo IV is implicated in
the polarized cleavage of a dCs tract which brings
about a detrimental effect on the replication of
dC-containing DNA.
INTRODUCTION
Endonuclease IV (Endo IV) encoded by denB of bacterio-
phage T4 is implicated in restriction of deoxycytidine
(dC)-containing DNA corresponding to the host
Escherichia coli or its own genomic DNA in the host
cells. Indeed, the synthesis of stable dC-substituted T4
(T4dC) genomic DNA requires a defective mutation of
denB in addition to mutations of gene 42 (which encodes
dCMP hydroxymethylase), gene 56 (dCTP/dUTPase) and
either gene 46 (46/47 exonuclease) or denA (endonuclease
II) (1). Under the denB
 , gene 42
 , gene 56
 , possibly
denA
  background, an additional mutation in alc (unf),
whose product shuts oﬀ transcription of T4dC DNA (2),
results in the generation of a plaque-forming T4 phage
containing dC-substituted DNA (T4dC phage) (3).
Furthermore, a deﬁciency in denB is indispensable for
the synthesis of stable T4dC genomic DNA (1) and denB
expression in E. coli cells is lethal (4), even though Endo
IV has little eﬀect on the degradation of T4dC (5) or host
(6–8) genomic DNA after infection of T4 phage. These
results suggest that Endo IV plays a crucial role in
inhibition of the replication of T4dC or host genomic
DNA rather than in its degradation.
Endo IV composed of 185 amino acid residues requires
Mg
2+ for activity, acts only on single-stranded (ss) DNA
and generates 50 termini containing exclusively dC (4,9–12,
H. Ohshima, N. Hirano and H. Takahashi, submitted for
publication). The enzyme does not cleave normal T4
genomic DNA-containing glucosylated deoxyhydroxy-
methylcytidine (gluc-dHMC) (4,9). Endo IV preferentially
recognizes short nucleotide sequences that include
50-dTdCdA-30 (4,12) in a condition where a unique dC
locates within a substrate oligonucleotide. Given that
Endo IV is highly toxic to E. coli cells, we have synthesized
the enzyme using a wheat germ cell-free protein synthesis
system (13) and puriﬁed to homogeneity (4, H. Ohshima,
N. Hirano and H. Takahashi, submitted for publication).
Recently, we have demonstrated that a six-base sequence
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(refers as a dC1–dC6 tract or a 6 dCs tract), 50-dC1dN2
dN3dN4dN5dC6-30 (where dN represents dA, dC, dG
or dT), is crucial for the eﬃcient cleavage by Endo IV,
and a third dC at the dN2dN3dN4dN5 region of a
dC1–dC6 tract restricts the cleavage activity at the
50-proximal dC1 site (restricted and polarized cleavage).
A third dC residue placed within a dCs tract enhances the
restricted and polarized cleavage. Furthermore, some of
dCs tracts having sizes larger than six bases (extended dCs
tract) also were shown to behave as a six dCs tract
(H. Ohshima, N. Hirano and H. Takahashi, submitted
for publication).
Replication of the E. coli chromosome occurs bidirec-
tionally from a single locus known as oriC (14,15),
whereas bacteriophage T4 makes use of two major replica-
tion mechanisms that are regulated to occur during certain
phases of the infection cycle (16,17). At early period of T4
infection, origin-dependent replication proceeds from
several origins and involves initiation from R-loops (18).
As infection progresses, origin-dependent replication is
repressed, and recombination-dependent replication pre-
dominates (19) and involves initiation from D-loops
formed by strand invasion (20). Given that R-loops,
D-loops and lagging strand of replication fork include
ss regions of DNA, the regions of ssDNA in these
replication-speciﬁc structures may become potential sub-
strates for Endo IV in vivo. If this is the case, Endo IV
might target certain sequences in the ssDNA regions of
these replication-speciﬁc structures and thereby eﬀectively
inhibit the replication. In this regard, we previously
identiﬁed that short nucleotide sequences that include
50-dT/dCdAdCdTdTdC-30 is the most susceptible to Endo
IV cleavage in vitro (H. Ohshima, N. Hirano and
H. Takahashi, submitted for publication), where the
slash indicates the cleavage site by Endo IV. However,
the mechanism of sequence recognition by Endo IV that is
crucial for the inhibition of replication of dC-containing
DNA remains unclear.
To elucidate in vivo function of Endo IV, in this study
we isolated two T4dC mutants with point mutations in
denB gene that result in the replacement of Trp
88 of Endo
IV with Arg [denB(W88R)] or that of Ser
176 with Asn
[denB(S176N)]. We synthesized the Endo IV enzymes
encoded by the mutant denB alleles and found that the
enzymatic activities of Endo IV(W88R) and Endo
IV(S176N) were 50.4 and 17.5% of that of wild-type
Endo IV, respectively. Neither of the two mutant alleles
had a detrimental eﬀect on the synthesis of T4dC genomic
DNA nor the growth of host cells. Furthermore, the
sequence 50-dCdTdT-30 located at the dN2dN3dN4dN5
region of a dC1–dC6 tract was shown to enhance cleavage
at the dC1 site by wild-type Endo IV but not by Endo
IV(S176N), indicating that the Ser
176 residue is crucial for
the restricted and polarized cleavage by Endo IV. These
results indicate that the Ser
176 residue of Endo IV impli-
cated in the restricted and polarized cleavage at the dC1
site of a dCdTdT-containing dC1–dC6 tract is responsible
for the Endo IV-mediated restriction of dC-containing
DNA in E. coli cells.
MATERIALS AND METHODS
Materials
Restriction and other enzymes for recombinant DNA
technology were obtained from Takara Shuzo. T4 and
T4dC genomic DNA were prepared as described pre-
viously (21). The plasmid pEUGFP was constructed as
described previously (22) and pGEX-6p-1 was obtained
from GE Healthcare. Escherichia coli strain KH5402-1
[ilv, thyA, thr(Am), trpE9829(Am), metE, deo, supF6(Ts)]
(23) was provided by the National Institute of Genetics
(Japan), and strains LE392 (supF58, supE44, hsdR514,
galK2, galT22, metB1, trpR55, lacY1) and MC1061
(sup8, hsdR, mcrB, araD139, araABC-leu7679, lacX74,
galU, galK, rpsL, thi) were described previously (24).
CI857 lysogen of LE392 and E. coli Bb were used as host
strains for T4 phages (24). T4GT7 (3), T4dC(+) (24) and
T4 amC87 (gene 42), amE51 (gene 56) and unf39x6 (alc-1)
were derived from our T4 phage stocks.
Oligonucleotide substrates used in this article were
purchased from Oligo Texas Co. and are listed in Table 1.
A 45-base oligonucleotide, 50-dTdAdGdAdTdTdTdAd
GdTdAdAdTdTdAdTdAdTdGdCdTdCdTdTdCdAdTd
TdAdGdAdAdAdAdAdTdTdAdTdTdTdGdTdGdA-30
(=Cy5-T4A), based on the sequence of T4 DNA and
labeled at its 50 end with Cy5, was commercially synthe-
sized (Sigma-Aldrich, USA).
Genetic manipulation of T4phagemutants and isolation
ofsingle point mutationsin T4denB
T4 phage cross and complementation test were performed
as described in a previous paper (24). Isolation of denB
mutations from denB-proﬁcient multiple mutant strain of
T4 was done as described previously (24). In brief,
T4GT7, which contains mutations in gene 42 (amC87),
gene 56 (amE51) and alc (unf39) in addition to the
deletion NB5060 (rII–denB), was genetically crossed
with an alc (unf39)-deﬁcient mutant having rII- and
denB-proﬁcient genes. Genetic cross was performed on
LE392 as host cells. LE392, LE392 (CI857), MC1061 and
Table 1. Oligonucleotide substrates used and their abbreviated names
Oligonucleotide Short name
a
50-(dC)45-30 [(dC)45]45/45
50-(dC)25-30 [(dC)25]25/25
50-(dA)5(dC)15(dA)5-30 [(dC)15]15/25
50-(dA)7(dC)11(dA)7-30 [(dC)11]11/25
50-(dA)9(dC)6(dA)10-30 [dCdCdCdCdCdC]6/25
50-(dA)10(dC)5(dA)10-30 [dCdCdCdCdC]5/25
50-(dA)12(dC)1(dA)12-30 [dC]1/25
50-(dA)9dCdTdTdTdTdC(dA)10-30 [dCdTdTdTdTdC]6/25
50-(dA)9dCdCdTdTdTdC(dA)10-30 [dCdCdTdTdTdC]6/25
50-(dA)9dCdTdCdTdTdC(dA)10-30 [dCdTdCdTdTdC]6/25
50-(dA)9dCdTdTdCdTdC(dA)10-30 [dCdTdTdCdTdC]6/25
50-(dA)9dCdTdTdTdCdC(dA)10-30 [dCdTdTdTdCdC]6/25
aSuﬃx numbers indicate the nucleotide length of the target sequence
(referred as a six-base tract) and total length of oligonucleotides,
respectively. Suﬃx number is often omitted in the text. A dC1–dC6 tract
is deﬁned as a hexanucleotide comprising two dC residues at the ﬁrst
and sixth positions and the sequences are shown in the parentheses [ ].
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respective mutation. After crossing on LE392, plaque
formers on LE392 (CI857)a t3 0 8C were screened for the
presence of ‘amber’ mutation(s) by spotting on Bb and
LE392. Then, phage clones giving no growth on Bb host
were further examined by genetic complementation tests
with amC87 (gene 42), amE51 (gene 56) on Bb cells. Thus,
rII- and denB-proﬁcient phage recombinants having
mutations in gene 42 (amC87) and gene 56 (amE51)
besides alc (unf39), were obtained. Two such T4 clones
that give plaques on MC1061 at  10
 4, but essentially no
plaque on Bb host cells were used for further study. These
clones may possibly have an additional mutation derived
from the original GT7 that aﬀects endonuclease II activity
(25). However, this does not aﬀect the results reported
here and therefore we do not mention this mutation later.
The plaque formers on MC1061 cells are expected to
have mutation in denB in addition to the mutations
in gene 42 (amC87), gene 56 (amE51) and alc (unf39).
Plaques appeared on MC1061 cells were puriﬁed and the
DNAs were subjected to the polymerase chain reaction
(PCR) with a 50 primer and a 30 primer (4) to amplify the
denB region. The sequence of this region was determined
by the dideoxy chain termination method to identify
individual points mutations of denB.
Constructionof denB expression plasmids
The plasmids pBRdenB
am, pBRdenB(W88R)
am and
pBRdenB(S176N)
am were constructed as described pre-
viously (4). The denB
am, denB(W88R)
am and
denB(S176N)
am genes, in which the TAC codon for
Tyr
38 is replaced with a TAG nonsense codon, were
constructed by PCR with a 50 primer containing a BamHI
site and a 30 primer containing a SalI site as well as with 50
and 30 mutagenic primers (4). The PCR products were
introduced into the BamHI–SalI sites of pBR322 (Takara
Shuzo) to yield pBRdenB
am, pBRdenB(W88R)
am and
pBRdenB(S176N)
am, and the resulting plasmids were
cloned in non-amber-suppressing host cells. The nucleo-
tide sequences of the plasmid inserts were conﬁrmed by
the dideoxy chain termination method. All PCR primers
were synthesized by Sigma-Aldrich. PCR was performed
for 25 cycles of incubation at 988C for 10s, 558C for 10s
and 728C for 30s with Prime STAR HS DNA polymerase
(Takara Shuzo) in a Takara PCR Thermal Cycler MP.
The eﬀect of denB alleles on E. coli growth was
examined by growth curve analysis of E. coli KH5402-1
cells (23) harboring pBRdenB
am, pBRdenB(W88R)
am or
pBRdenB(S176N)
am. The cells were grown overnight at
428C in LB liquid broth containing thymine and ampicillin
at 2 and 100mg/ml, respectively (LB-Thy-Amp). The
resulting cells were used to inoculate (1:100 dilution)
fresh LB-Thy-Amp liquid broth and were incubated
with shaking ( 140min
 1)a t4 2o r3 0 8C. Samples were
removed from the cultures at various times to measure the
optical density at 600nm (OD600). Given that E. coli
KH5402-1 cells harbor a temperature-sensitive (Ts) allele
of the supF suppressor gene, the cells transformed with
pBRdenB
am, pBRdenB(W88R)
am or pBRdenB(S176N)
am
would be expected to produce the encoded Endo IV
proteins when grown at 308C but not at 428C.
Production andpurification of GST-Endo IV fusion proteins
A DNA fragment encoding a glutathione S-transferase
(GST) fusion protein of Endo IV was constructed and
subjected to in vitro transcription as described previously
(4). The resulting mRNA was then translated in a wheat
germ cell-free protein synthesis system with the use of a
dialysis cup (molecular size cutoﬀ of 12000 Da; Daiichi
Pure Chemicals) as described previously (4). The dialysis
unit containing the reaction mixture was incubated for
96h at 268C, with the original amount of substrate mRNA
being supplemented and the external solution changed
every 24h. The GST-Endo IV fusion protein was puriﬁed
as described previously (4). The fusion protein was cleaved
by incubation with PreScission protease (10U/ml; GE
Healthcare) for 4h at 48C in a glutathione-Sepharose 4B
MicroSpin column (GE Healthcare). The ﬂow-through
fraction contained a protein of the predicted size for Endo
IV (21.1kDa), as revealed by SDS–polyacrylamide gel
electrophoresis on a 12% gel and staining with Coomassie
brilliant blue. The protein concentration of this fraction
was estimated by densitometric analysis with NIH Image
software and the use of trypsin inhibitor (20.1kDa) as a
standard. The Endo IV mutant proteins were obtained as
described for the wild-type protein.
Kinetic analysis of Endo IV activity
Hydrolysis of oligonucleotide substrates (10mM) was
performed as described previously (4, H. Ohshima, N.
Hirano and H. Takahashi, submitted for publication).
Enzyme and substrate were incubated for 30min at 378C
in a reaction mixture (20ml) containing 10mM Tris–HCl
(pH 8.0), 10mM MgCl2, 1mM dithiothreitol and bovine
serum albumin (0.1mg/ml). The reaction was stopped by
the addition of 30ml of 25mM EDTA (pH 8.0) and 50ml
of 10% trichloroacetic acid. The resulting mixture (100ml)
was maintained on ice for 15min and then centrifuged at
5000g for 15min at 48C. The amount of acid-soluble
nucleotides in the supernatant fraction was quantiﬁed by
measurement of absorbance at 260nm, with molar
absorption coeﬃcients of 15200, 7050, 12010 and
8400M
 1cm
 1 for dA, dC, dG and dT, respectively.
One unit was deﬁned as the amount of enzyme producing
1mmol of acid-soluble nucleotides per minute, and speciﬁc
activity was deﬁned as the enzymatic activity per milli-
gram of enzyme. The amount of enzyme was varied such
that the amount of product increased in proportion to that
of the enzyme. The concentration of the substrate was also
varied from 3 to 30mM such that it spanned the Km.
Oligonucleotide substrates were synthesized by Texas
Genomics Japan. Kinetic parameters were determined by
a least-squares ﬁt of the data in Lineweaver–Burk plots.
Cleavage analysis ofan oligonucleotide corresponding
to aT4DNA sequence by Endo IV
Hydrolysis of a 45-base oligonucleotide (Cy5–T4A, see
Materials section) based on the sequence of T4 DNA and
labeled at its 50 end with Cy5 (Sigma-Aldrich) was
6694 Nucleic Acids Research, 2007, Vol. 35, No. 20performed as described above for the Endo IV assay at a
substrate concentration of 10mM and enzyme concentra-
tions of either 0.5–4mg/ml for wild-type Endo IV or
1–8mg/ml for Endo IV(S176N). The reaction products
were separated by electrophoresis on a 10% polyacryl-
amide gel containing 7M urea and were visualized with a
Variable Image Analyzer Typhoon 8600 (GE Healthcare).
RESULTS
Screening forsingle point mutationsin denB
To clarify the biological signiﬁcance and function of denB
and the gene product, Endo IV, we screened and
characterized the denB mutations and their gene products.
The isolation of denB mutations was originally described
in a previous paper (24). T4 mutant phages having
multiple mutations in gene 42 (amC87), gene 56 (amE51)
and alc (unf39) were plated on MC1061 strain as the host
and plaque formers were further characterized in details
(see Materials and Methods section). Thus, we identiﬁed
two types of T4 phage mutants with a single point
mutation in denB besides the multiple mutations, which
resulted in plaque-formable T4 phages with dC-containing
DNA on a restriction-minus and suppressor-negative
host, such as MC1061. By sequence analysis, the ﬁrst
type of denB mutation revealed to have a transition
mutation (U to C) in the codon Trp
88 (UGG) changed to
codon Arg (CGG). This mutation coincided with the
denB-s19 mutation of T4dC(+) phage (24) and was
named as denB(W88R). The second type of denB mutation
had also a transition mutation (G to A) which resulted in a
change of codon from Ser
176 (AGC) to Asn (AAC), and
was named as denB(S176N).
Detrimental effectof wild-type and mutant-type
denB alleles on E. coli growth
As described in a previous paper (4), attempts to clone
the wild-type denB gene in several diﬀerent expression
vectors, including pET21a under strict control of the T7
promoter, were unsuccessful, presumably because of a
highly toxic eﬀect of the denB product (Endo IV) on the
host E. coli cells. We therefore examined the eﬀect of denB
expression on E. coli by using KH5402-1 (supF6Ts) cells.
The E. coli strain has a temperature-sensitive allele of the
supF suppressor gene (23) with a plasmid containing an
amber mutant allele of denB, in which the TAC codon for
Tyr
38 is mutated to a TAG nonsense codon. The E. coli
KH5402-1 cells were used to examine the eﬀects of T4
phage-encoded denB (4) and ndd (26) genes on the growth
of host cells, and a signiﬁcant growth defect was observed
when KH5402-1 cells transformed with a plasmid contain-
ing an amber mutant allele of denB (4) or ndd (26) gene
were cultured at 308C.
To know whether the denB(W88R) and denB(S176N)
alleles allow the growth of E. coli cells, we transformed
KH5402-1 cells with a plasmid-containing denB mutant
alleles in which an amber mutation had been introduced at
the codon for Tyr
38 (TAC). Cells cultured at 308C would
thus be expected to produce the full-length Endo IV
mutant enzymes, whereas those cultured at 428C would
not. We previously showed that culture at 308Co f
KH5402-1 cells transformed with pBRdenB
am reduced
colony-forming ability compared with that apparent at
428C, and most (99%) of the original colonies that formed
at 308C did not give rise to colonies in the presence of
the selection drug (ampicillin) at 428C (4). These results
indicated that most colonies that formed at 308C consisted
of cells lacking pBRdenB
am and that most cells that
expressed wild-type Endo IV were not viable. Here we
examined the eﬀects of denB expression on the growth of
KH5402-1 cells transformed with pBRdenB
am. KH5402-1
cells transformed with pBRdenB
am revealed essentially
no growth at 308C, but normal growth at 428C, and
KH5402-1 cells transformed with pBR322 grow normally
both at 30 and 428C (Figure 1A). In contrast, the growth
at 42 or 308C of KH5402-1 cells transformed with
pBR322 containing amber mutant forms of denB(W88R)
or denB(S176N) alleles did not diﬀer substantially from
that of those transformed with pBR322 alone (Figure 1B).
These results suggested that E. coli cells expressing the
intact Endo IV mutant enzymes, Endo IV(W88R)
and Endo IV(S176N), were viable and that, in contrast
Figure 1. Eﬀect of denB(W88R) and denB(S176N) alleles on E. coli growth. Cultures of KH5402-1 cells harboring either pBR322 or pBRdenB
am
(A) or pBRW88R
am or pBRS176N
am (B) were grown overnight in LB-Thy-Amp liquid broth at 428C, and the cells were then used to inoculate fresh
LB-Thy-Amp liquid broth and incubated at 428Co r3 0 8C. Samples were removed at the indicated times for determination of OD600. Data are means
of values from two independent experiments.
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detrimental eﬀect on the host cells.
EnzymaticactivitiesofEndoIV(W88R)andEndoIV(S176N)
To examine the Endo IV activity encoded by these denB
mutant alleles, we synthesized wild-type and mutant
Endo IV as GST fusion proteins by in vitro translation
with a wheat germ cell-free protein synthesis system (4).
The amounts of puriﬁed Endo IV(W88R) and Endo
IV(S176N) obtained were similar to that of wild-type
Endo IV. We previously developed the acid-solubility
assay for Endo IV activity (4). The acid-solubility assay
is based on the endonucleolytic activity of Endo IV to
generate acid-soluble products from an acid-insoluble
oligonucleotide substrate. All of the oligonucleotide subst-
rates were so designed as to be acid-insoluble before Endo
IV cleavage and to generate acid-soluble products after
the cleavage. The acid-solubility assay was successfully
applied to the kinetic analysis of Endo IV with oligo-
nucleotide substrates consisting of two stretches of
appropriate length of oligo(dA) attached to both the
50 and 30 termini of varied dC-containing sequence
(4, H. Ohshima, N. Hirano and H. Takahashi, submitted
for publication). All of the oligonucleotide substrates used
in this study were identical to those used in the previous
study (H. Ohshima, N. Hirano and H. Takahashi,
submitted for publication).
The denB product of T4dC phages would not be
expected to possess enzymatic activity, because Endo IV
catalyzes endonucleolytic cleavage of dC-containing
ssDNA. To conﬁrm this expectation, we examined the
enzymatic activities of Endo IV(W88R), Endo IV(S176N)
and wild-type Endo IV with 45-base 50-(dC)45-30
([(dC)45]45/45), 25-base 50-(dC)25-30 ([(dC)25]25/25) and
various oligonucleotides as substrates listed in Table 1.
The activity of wild-type Endo IV decreased as the length
of dC tract decreased from 15 to 5, and its enzymatic
activity with [dC]1/25 did not diﬀer from that with
[dCdCdCdCdC]5/25 (Figure 2). As expected, Endo
IV(W88R) showed essentially no Endo IV activity,
which was 50.4% of that of wild-type Endo IV with
[(dC)25]25/25. In contrast, Endo IV(S176N) showed a
substantial level of Endo IV activity, which was 17.5%
of that of wild-type Endo IV with [(dC)25]25/25 and equal
to that of wild-type Endo IV with [dCdCdCdCdC]5/25,
even though the denB(S176N) allele allowed the synthesis
of T4dC genomic DNA and the growth of host cells.
In addition, the activity of wild-type Endo IV increased
markedly (by a factor of 20) as the length of dC tract
increased from ﬁve to six, whereas that of Endo
IV(S176N) did not (by a factor of 2). These results
indicated that the S176N mutation might aﬀect the
sequence preference of Endo IV.
Sequencepreferences of Endo IV andEndo IV(S176N)
To examine a diﬀerence in the enzymatic activity with
[dCdCdCdCdCdC]6/25 between wild-type Endo IV and
Endo IV(S176N) in more detail, we compared their kinetic
parameters for the hydrolysis of this substrate (Figure 3).
The Vmax of Endo IV(S176N) with [dCdCdCdCdCdC]6/25
was reduced by a factor of 1.9 and its Km was increased by
a factor of 1.6 compared with the corresponding values
of wild-type Endo IV, indicating that the denB(S176N)
mutation resulted in both a lower hydrolysis rate and
a lower substrate aﬃnity.
Figure 2. Eﬀect of dC tract length on enzymatic activities of wild-type
and mutant (S176N or W88R) forms of Endo IV. Enzymatic activity
was determined by measurement of the amount of acid-soluble
nucleotides released from the substrate (10mM). All substrates with
the exception of [(dC)45]45/45 contained 25nt. The speciﬁc activity of the
wild-type (WT) enzyme with the [(dC)25]25/25 substrate was  8.0 U/mg.
Relative activity was calculated by dividing the enzymatic activity of
each Endo IV enzyme observed with each substrate by that apparent
with the wild-type enzyme and [(dC)25]25/25 as substrate. Data are
means of values from two independent experiments.
Figure 3. Analysis and comparison of the sequence preferences of wild-
type and S176N mutant forms of Endo IV. The Vmax (A) and Km (B)o f
the wild-type (WT) and S176N mutant forms of Endo IV were deter-
mined with series of 25-base oligonucleotides [dCdYdYdYdYdC]6/25
(where dY represents dT or dC) and shown by black columns (WT)
and white columns (S176N) in the ﬁgure. Data are means of values
from two independent experiments.
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increase compared with that of wild-type Endo IV as the
length of dC tract increased from ﬁve to six (Figure 2),
the denB(S176N) mutation might aﬀect recognition of
50-dC1dN2dN3dN4dN5dC6-30 (dC1–dC6) tract by Endo IV
(H. Ohshima, N. Hirano and H. Takahashi, submitted for
publication). To examine this possibility, we compared
the kinetic parameters of wild-type Endo IV and Endo
IV(S176N) for the hydrolysis of [dCdTdTdTdTdC]6/25,
[dCdCdTdTdTdC]6/25, [dCdTdCdTdTdC]6/25, [dCdTdTd
CdTdC]6/25 and [dCdTdTdTdCdC]6/25 oligonucleotides
(Figure 3). The Km and Vmax of Endo IV(S176N) with
[dCdTdTdTdTdC]6/25 were similar to those of wild-type
Endo IV with this substrate (Figure 3), indicating that the
denB(S176N) mutation does not aﬀect recognition of
the dC1 and dC6 residues of a dC1–dC6 tract by Endo IV.
In contrast, the Vmax values of wild-type Endo IV with
[dCdCdTdTdTdC]6/25 and [dCdTdCdTdTdC] 6/25, both of
which contain 50-dCdTdT-30 at the dN2dN3dN4dN5
region, were  2.5-fold greater than its Vmax with [dCdT
dTdTdTdC]6/25 (Figure 3A), whereas the Vmax values of
Endo IV(S176N) with all the substrates tested were similar
to each other (Figure 3A), indicating that the denB
(S176N) mutation disrupts recognition of a 50-dCdTdT-30
sequence located at the dN2dN3dN4dN5 region of a
dC1–dC6 tract by Endo IV. In addition, the Km values
of wild-type Endo IV with [dCdCdTdTdTdC]6/25, [dCdTd
CdTdTdC]6/25, [dCdTdTdCdTdC]6/25 and [dCdTdTdTd
CdC]6/25, all of which contain a dC residue at the
dN2dN3dN4dN5 region, were  1.6-fold lower than its
Km with [dCdTdTdTdTdC]6/25 (Figure 3B), whereas the
Km values of Endo IV(S176N) with all the substrates
tested were substantially identical (Figure 3B), indicating
that Endo IV(S176N) markedly reduces the aﬃnity to the
third dC residue within a dC1–dC6 tract. Thus, the mutant
enzyme is unable to recognize a 50-dCdTdT-30 sequence
within a dC1–dC6 tract and did not show enhanced
cleavage at the same site observed by wild-type Endo IV.
Endo IV(S176N) isnotable tocleave atthe 5’ proximal
dC(dC1)i nad C 1–dC6 tract
We have previously demonstrated that a 50-dCdTdT-30
sequence placed at the dN2dN3dN4dN5 region of a
dC1–dC6 tract directs the cleavage activity of Endo IV at
the dC1 site (H. Ohshima, N. Hirano and H. Takahashi,
submitted for publication). Since Endo IV(S176N) did not
recognize 50-dCdTdT-30 element within a dC1–dC6 tract,
the denB(S176N) mutation might aﬀect the restricted and
polarized cleavage at the dC1 site by Endo IV. To examine
this possibility, we compared the cleavage patterns of
a Cy5-labeled 45-base oligonucleotide corresponding to
a T4 DNA sequence containing a 50-dC1dT2dC3dT4dT5
dC6-30 tract (Cy5–T4A) by wild-type Endo IV and Endo
IV(S176N) (Figure 4). The maximal concentrations of
wild-type Endo IV and Endo IV(S176N) used in these
assays were 4 and 8mg/ml, respectively, and the cleavage
products were separated by electrophoresis on a poly-
acrylamide gel containing 7M urea. The substrate
contains three dC residues at positions 20, 22 and 25,
which correspond to the dC1,d C 3 and dC6 positions,
respectively, of the 50-dC1dT2dC3dT4dT5dC6-30 tract.
Wild-type Endo IV (Figure 4A) cleaved exclusively at
the dC1 site in dG19–dC20–dT21 (marked c) while Endo
IV(S176N) (Figure 4B) cleaved most eﬃciently at the dC6
site in dT24–dC25–dA26 (marked a) and less eﬃciently at
the dC3 site in dT21–dC22–dT23 (marked b), indicating that
the denB(S176N) mutation disrupts the restricted and
polarized cleavage at the dC1 site (marked c) of the
50-dC1dT2dC3dT4dT5dC6-30 tract by Endo IV. These
results suggest that Ser
176 of Endo IV recognizing
the third dC residues included 50-dCdTdT-30 within a
dC1–dC6 tract is crucial for the restricted and polarized
cleavage at the dC1 site by Endo IV. In addition, although
Endo IV(S176N) has lost the ability to restrict the
cleavage site to the dC1 site, it retains an ability to
cleave dC-speciﬁc manner and a 50-dTdCdA-30 preference
that is characteristic of wild-type Endo IV (4).
DISCUSSION
Roleof Ser
176 inthe sequence preference of EndoIV
Only limited information on the sequence preference of
Endo IV has been available (4,12), and the small number
of Endo IV-related proteins in the genome sequence
databases has restricted the amount of insight provided
by such proteins into the mechanism of sequence recogni-
tion by Endo IV. Recently, we have found that
Figure 4. Comparison of cleavage patterns of oligonucleotide contain-
ing the 50-dCdTdCdTdTdC-30 corresponding to a T4 DNA sequence by
wild-type and S176N mutant forms of Endo IV. A 45-base oligo-
nucleotide (Cy5–T4A) based on the sequence of T4 DNA and labeled
at its 50 end with Cy5 was used as the substrate (10mM) for assay of
the activity of wild-type (0.5, 1.0, 2.0 or 4.0mg/ml) (A) or S176N
mutant (1.0, 2.0, 4.0 or 8.0mg/ml) (B) forms of Endo IV. The reaction
products were separated by electrophoresis on a 10% polyacrylamide
gel containing 7M urea and were visualized with an image analyzer.
Lane ( ) represents a reaction mixture incubated in the absence of
enzyme. Lane M represents a mixture of oligonucleotides labeled at
their 50 ends with Cy5 and with sequences identical to those of residues
1 to 19, 1 to 21 or 1 to 24 of the substrate. Cleavage sites of the
substrate are indicated by arrows, and dC sites in dG19–dC20–dT21,
dT21–dC22–dT23 and dT24–dC25–dA26 are indicated by a, b and c,
which correspond to the dC1,d C 3 and dC6 sites of the 50-dC1dT2
dC3dT4dT5dC6-30 tract, respectively.
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for the eﬃcient cleavage by wild-type Endo IV (Figure 5A)
(H. Ohshima, N. Hirano and H. Takahashi, submitted for
publication). A third dC residue located at the dN2dN3
dN4dN5 region of a dC1–dC6 tract improves the aﬃnity of
Endo IV to substrates, and a 50-dCdTdT-30 sequence at
the dN2dN3dN4dN5 region restricts and enhances the
Endo IV cleavage at the dC1 site (Figures 4A and 5A)
(H. Ohshima, N. Hirano and H. Takahashi, submitted for
publication).
In this report, we have shown that the aﬃnity of
Endo IV(S176N) to the third dC residue located at the
dN2dN3dN4dN5 region is markedly reduced and therefore
a5 0-dCdTdT-30 sequence at the dN2dN3dN4dN5 region
does not either restrict or enhance the cleavage activity of
Endo IV(S176N) at the dC1 site (Figures 4B and 5B),
whereas Endo IV(S176N) retains an ability to cleave
dC-speciﬁc manner and a 50-dTdCdA-30 preference
(Figure 4B). These results suggest that the Ser
176 residue
that contributes to recognition of the third dC residue
located at the dN2dN3dN4dN5 region of a dC1–dC6 tract
is crucial for enhancement of the cleavage activity of
Endo IV with a dCdTdT-containing dC1–dC6 tract and
the restricted and polarized cleavage at the dC1 site by
Endo IV. In addition, because the Ser
176 residue markedly
increases the hydrolysis rate of Endo IV with a dCdTdT-
containing dC1–dC6 tract, Ser
176 may contribute to
accommodation of the cleavage site (dC1 site) to the
active site of Endo IV enzyme, resulting in the eﬃcient
cleavage at the dC1 site by Endo IV.
Possible mechanismof Endo IV action in vivo
A deﬁciency in denB suppresses the lack or arrest of T4dC
genomic DNA synthesis in a gene 56
  (1,27,28) or
gene 42
 , gene 46
 , gene 56
  (1) background, respectively,
and T4dC phage mutants with a denB
+ background cease
synthesizing their genomic DNA within 30min after
infection (1). In addition, several denB point mutations
that allow stable T4dC genomic DNA synthesis in
the gene 56
  background result in a complete loss of
Endo IV activity (conﬁrmed in vitro) (29). Moreover, denB
expression in E. coli cells is lethal (4). Together, these
various observations so far suggest that a lack of
Endo IV activity is indispensable for the replication of
dC-containing DNA.
We have now identiﬁed the denB(W88R) and
denB(S176N) alleles that allowed plaque-forming T4dC
phage in the gene 42
 , gene 56
 , alc
 , possibly denA
 
background and did not exhibit the detrimental eﬀect on
host cell growth, suggesting that these denB alleles do not
inhibit the replication of both T4dC and host genomic
DNAs. Indeed, Endo IV(W88R) exhibited essentially no
Endo IV activity (50.4% of that of wild-type Endo IV),
consistent with the suggested indispensability of a deﬁci-
ency of denB for the replication of dC-containing DNA.
However, Endo IV(S176N) possessed a substantial level of
Endo IV activity (17.5% of that of wild-type Endo IV)
and a 50-dTdCdA-30 preference. The comparison of the
enzymatic activities of wild-type Endo IV and Endo
IV(S176N) indicated that the denB(S176N) mutation did
not enhance the cleavage activity of Endo IV with a
dCdTdT-containing dC1–dC6 tract and lost the restricted
and polarized cleavage at the dC1 site, which might be
responsible for the loss of the ability of Endo IV to restrict
dC-containing DNA in the host cells.
Replication of E. coli genome initiates from a single
origin, oriC (14,15), whereas bacteriophage T4 makes use
of two major mechanisms of replication initiation, which
involve R-loops at several origins, oriA, oriE, oriF and
oriG, and D-loops in the process of recombination-
dependent replication (16–20). However, because
dCdTdT-containing dC1–dC6 tracts are not found abun-
dantly in the proximal regions of any of T4 and E. coli
origins, Endo IV may not speciﬁcally target the initiation-
speciﬁc structures of replication at these origins but target
various ssDNA regions of replicating DNA, such as those
involved in R-loops, D-loops and lagging strand of repli-
cation fork. In fact, no sequence consisting of more
than six consecutive dC residues crucial for the eﬃcient
cleavage by Endo IV is found in T4 genomic DNA
(168 903bp), whereas dCdTdT-containing dC1–dC6 tracts
being the enhanced target sequence by Endo IV are found
Figure 5. Schematic representation of the dCs tract model for restricted
dC-speciﬁc cleavage by Endo IV and the role of Ser
176. (A) A dCs tract
is shown as a horizontal line with two closed boxes (dC6 and dC1) from
the 30 to 50 direction. A downward arrow indicates the point where an
endonucleolytic cleavage by Endo IV occurs and a rightward arrow
indicates the element enhancing and restricting the enzymatic activity
(Vmax and Km) of Endo IV. Endo IV binds to both dC1 and dC6
residues, and especially the Ser
176 residue of the enzyme contributes to
recognition of a dC residue located at the dN2dN3dN4dN5 region of
a dCs tract and leads the enzyme to exhibit cytotoxicity and recognize
the 50-dCdTdT-30 trinucleotide element enhancing the cleavage activity
at the dC1 site. This interaction is required for the restricted and pola-
rized cleavage at the dC1 site by Endo IV. (B) Replacement of Ser
176
with Asn disrupts the interaction between Endo IV and a dC residue
located at the dN2dN3dN4dN5 region, resulting in the losses of
restricted and polarized cleavage at the dC1 site and cytotoxicity.
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of 1 per 938bp. Thus, recognition of the sequences that
include a dCdTdT-containing dC1–dC6 hexanucleotide
tract in T4 genomic DNA by Endo IV may be crucial for
the eﬀective inhibition of T4dC genomic DNA synthesis.
The mechanism of restriction of dC-containing
DNA in the host cells by Endo IV remains elusive. The
denB(S176N) mutation reduced the enzymatic activity
with the oligo(dC) substrates and the Vmax/Km values with
the substrates containing a dCdTdT-containing dC1–dC6
tract only by a factor of  5 (Figures 2 and 3), raising
a question why the denB(S176N) allele allows both T4
and E. coli replication-apparatuses to replicate their
dC-containing genomic DNAs. A ﬁve-fold reduction of
the Endo IV activity in vivo may simply make both T4
and E. coli replication-apparatuses possible to replicate
dC-containing DNA due to contribution of the endo-
genous repair systems. Alternatively, if the cleavage at the
dC1 site of a dCdTdT-containing dC1–dC6 tract is critical
for the inhibition of both replications by T4 and E. coli
replication-apparatuses, a loss of the restricted cleavage
at the dC1 site of the tract may greatly reduce the accu-
mulation of damage to both replicating DNAs in vivo.
In vivo studies of the eﬀects of denB mutant alleles on
E. coli growth, which retain the restricted cleavage at the
dC1 site of the tract but reduce the enzymatic activity, may
provide insight into the mechanism of Endo IV-mediated
restriction of dC-containing DNA in E. coli cells.
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